Evidence map›Paper›PMID 19756525›Full record

ArticlePsychopharmacology2009

A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.

Antonio Ferragud, Clara Velázquez-Sánchez, Vicente Hernández-Rabaza, Amparo Nácher, Virginia Merino, Miguel Cardá, Juan Murga, Juan J Canales

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Tamoxifen Directly Interacts with the Dopamine Transporter.The Journal of pharmacology and experimental therapeutics · 2018
    Article
  3. Dopamine Transporter Dynamics ofThe Journal of pharmacology and experimental therapeutics · 2018
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Monoamine transporters: vulnerable and vital doorkeepers.Progress in molecular biology and translational science · 2011
    Review
  15. Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Antonio FerragudBiopsychology and Comparative Neuroscience Group, Cavanilles Institute (ICBiBE), University of Valencia-General Foundation & Red de Trastornos Adictivos (RETICS), Polígono de la Coma s/n, Paterna, 46980, Valencia, Spain.
Clara Velázquez-Sánchez
Vicente Hernández-Rabaza
Amparo Nácher
Virginia Merino
Miguel Cardá
Juan Murga
Juan J Canales
Universitat de València · ESUniversitat Jaume I · ESFundación General · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleN-substituted benztropine analogs are potent dopamine uptake inhibitors that display pharmacokinetic/dynamic properties consistent with the profile of a substitute medication for cocaine addiction.

objectivesThe purpose of the present experiments was to characterize in rats the addictive-like properties of one such analog, 3 alpha-[bis(4'-fluorophenyl)methoxy]-tropane (AHN-1055), incorporating probes of its stimulant and incentive/motivational effects and of its ability to influence cocaine self-administration.

methodsWe used open field activity and drug self-administration assays. To examine the effects of AHN-1055 on locomotor behavior, the analog was administered alone (0, 1, 3, and 10 mg/kg intraperitoneally) and in combination with cocaine (15 mg/kg i.p.). The influence of AHN-1055 on cocaine's intake was studied by administering the analog (0, 3, and 10 mg/kg i.p.) before the start of the self-administration sessions. To compare the addictive-like properties of AHN-1055 and cocaine, progressive ratio performance and abstinence-induced context-conditioned relapse were evaluated.

resultsAHN-1055 evoked robust and sustained locomotor activity when administered alone and increased cocaine-induced locomotor stimulation. Notably, the analog showed by comparison to cocaine weak reinforcing efficacy in a modified progressive ratio schedule of drug reinforcement, and contrary to cocaine, it showed no ability to promote context-conditioned relapse to drug seeking following stable self-administration and abstinence. Further, AHN-1055 treatment blocked cocaine intake dose-dependently in rats with a steady history of cocaine self-administration without reducing responding for sucrose, a natural reward.

conclusionsThese findings demonstrate essential psychopharmacological differences between AHN-1055 and cocaine and highlight important properties of the analog as a possible pharmacotherapy in cocaine addiction.

Indexed as

AnimalsBehavior, AnimalBenztropineCocaineCocaine-Related DisordersDopamine Uptake InhibitorsDose-Response Relationship, DrugMaleMotor ActivityRatsRats, Long-EvansReinforcement ScheduleRewardSelf AdministrationSucroseBenztropineCocaineDopamine Uptake InhibitorsN-methyl-3-(bis(4'-fluorophenyl)methoxy)tropaneSucrose

Identifiers

PMID19756525
OpenAlexW2038208342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.